European Case Law Identifier: | ECLI:EP:BA:2011:T041807.20110504 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 04 May 2011 | ||||||||
Case number: | T 0418/07 | ||||||||
Application number: | 97906572.9 | ||||||||
IPC class: | C07K 16/24 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Human antibodies that bind human TNFalpha | ||||||||
Applicant name: | Abbott Biotechnology Ltd. | ||||||||
Opponent name: | Hepworth, John Malcolm | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request: Sufficiency of disclosure, inventive step (yes) Copying services for multiple representatives (no) Provision of translation in oral proceedings (no) Requests for decision prior to oral proceedings (no) Admissibility of late filed documents (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070418eu1.html
Date retrieved: 17 May 2021
15 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
EPC Implementing Rules
Offical Journal of the EPO
Case Law Book: III Amendments
XCLR III F 3 Derogations from the language of the proceedings in written proceedings and in oral proceedings